Report cover image

Aesthetic Injectables Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

Publisher GlobalData
Published Apr 29, 2024
Length 193 Pages
SKU # GBDT18798848

Description

Aesthetic Injectables Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update


Summary

GlobalData's Medical Devices sector report, “Aesthetic Injectables Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Aesthetic Injectables pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Aesthetic Injectables refer to gel-like substances that are injected beneath the skin to restore a more youthful appearance. Aesthetic Injectables achieve providing a more youthful appearance by increasing the volume of sunken cheeks or temples, reducing lines around nose and mouth (marionette lines and smile lines), plumping up lips and enhancing facial contour.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Aesthetic Injectables under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Aesthetic Injectables and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to Buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Aesthetic Injectables under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

193 Pages
  • About GlobalData
    • Aesthetic Injectables Overview
    • Aesthetic Injectables - Pipeline Products by Stage of Development
    • Aesthetic Injectables - Pipeline Products by Segment
    • Aesthetic Injectables - Pipeline Products by Territory
    • Aesthetic Injectables - Pipeline Products by Regulatory Path
    • Aesthetic Injectables - Pipeline Products by Estimated Approval Date
    • Aesthetic Injectables - Ongoing Clinical Trials
    • Aesthetic Injectables Companies - Pipeline Products by Stage of Development
    • Aesthetic Injectables - Companies Pipeline Products by Stage of Development
    • Acro Biomedical Co Ltd Company Overview
    • Advanced Aesthetic Technologies Inc Company Overview
    • Aeon Astron Corporation Company Overview
    • Aesthetic Medical Device Company Overview
    • Allergan Aesthetics Company Overview
    • Almirall Ltd Company Overview
    • Aquavit Pharmaceuticals Inc Company Overview
    • Beijing MeiYan KongJian Technology Co Ltd Company Overview
    • BioPlus Co Ltd Company Overview
    • BioSmart Nanotechnology Ltda Company Overview
    • Bioxis Pharmaceuticals Company Overview
    • BMG Pharma SpA Company Overview
    • Bmi Korea Co Ltd Company Overview
    • CellPraxis Company Overview
    • Celltrix AB Company Overview
    • Collplant Biotechnologies Ltd Company Overview
    • Croma-Pharma GmbH Company Overview
    • Dexlevo Inc Company Overview
    • Dongkook Pharmaceutical Co Ltd Company Overview
    • EmulTech BV Company Overview
    • Establishment Labs SA Company Overview
    • Evolus Inc Company Overview
    • Fillmed Laboratoires Company Overview
    • G2GBIO Inc Company Overview
    • Galderma SA Company Overview
    • Hallura Ltd Company Overview
    • Histogen Inc Company Overview
    • Hugel Inc Company Overview
    • Innova Medical Design Company Overview
    • Innovia LLC Company Overview
    • inSoma Bio Inc Company Overview
    • Inventage Lab Inc Company Overview
    • Jinwoo Bio Co Ltd Company Overview
    • Juvenis Ltd Company Overview
    • Khorionyx SA Company Overview
    • KiOmed Pharma Company Overview
    • Laboratoires Vivacy Company Overview
    • LG Chem Ltd Company Overview
    • LifeSprout Inc Company Overview
    • Medytox Inc Company Overview
    • Merz Aesthetics Company Overview
    • Mesoestetic Pharma Group SL Company Overview
    • Moma Therapeutics Inc Company Overview
    • N8 Medical LLC Company Overview
    • Oligo Medic Inc Company Overview
    • Oxartis Ltd Company Overview
    • PB&B SA Company Overview
    • Peptron Inc Company Overview
    • PetVivo Holdings Inc Company Overview
    • Q-Med AB Company Overview
    • Samyang Biopharmaceuticals Corp Company Overview
    • Samyang Holdings Corp Company Overview
    • Sebana Medical Ltd Company Overview
    • Shanghai Haohai Biological Technology Co Ltd Company Overview
    • Shin Poong Pharm Co Ltd Company Overview
    • Silk Medical Aesthetics Inc Company Overview
    • Sinclair Pharma Ltd Company Overview
    • Sofregen Medical Inc Company Overview
    • So-Young International Inc Company Overview
    • Spiderwort Company Overview
    • SunMax Biotechnology Co Ltd Company Overview
    • SwiftPharma BV Company Overview
    • TEI Biosciences Inc (Inactive) Company Overview
    • Tempo Therapeutics Inc Company Overview
    • Teoxane SA Company Overview
    • Tetratherix Pty Ltd Company Overview
    • Tissueform Inc Company Overview
    • TruElastin Laboratories Inc Company Overview
    • Trylle Skin Health Inc Company Overview
    • University of California Santa Barbara Company Overview
    • University of Missouri Company Overview
    • Volumina Medical SA Company Overview
    • Apr 08, 2024: CGBio Targets European Aesthetic Market, Unveils Suture `LUXX' and `EGF Skin Booster' for the First Time
    • Mar 25, 2024: CGBio Discovers a Breakthrough in "Cartilage" Regeneration, Demonstrates the Regenerative Capabilities of "Hyaluronic Acid Gel" for Cartilage
    • Mar 21, 2024: Allergan Aesthetics Continues to Champion Individuality, Drive Innovation and Lead with Integrity as It Hosts Expert Led Symposia at AMWC 2024
    • Mar 05, 2024: JUVEDERM VOLUMA XC For Temple Hollows Receives U.S. FDA Approval
    • Mar 05, 2024: JUVÉDERM VOLUMA XC For Temple Hollows Receives U.S. FDA Approval
    • Mar 04, 2024: Revance Therapeutics Announces Proposed $100M Share Offering
    • Mar 01, 2024: Evolus Announces Results from European Head-to-Head Filler Trial
    • Feb 27, 2024: Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024
    • Feb 27, 2024: LG Chem to Raise 1 tln Won in Bond Sale
    • Feb 22, 2024: AbbVie Selling $15 Billion Bonds to Buy ImmunoGen, Cerevel
    • Feb 07, 2024: Galderma Launches `Next', a Ground-Breaking Trend Report That Unveils the Future of Aesthetics
    • Feb 05, 2024: AbbVie's Full Year 2023 Sees 6.4% Net Revenue Drop
    • Feb 02, 2024: Galderma Celebrates 25 Years of Excellence in Biostimulation With Sculptra at the 2024 IMCAS
    • Jan 22, 2024: Galderma Announces Regulatory Approval for Restylane SHAYPE, a new Hyaluronic Acid Injectable Designed for Augmenting the Chin Region
    • Jan 04, 2024: AbbVie to Host Full-Year and Fourth-Quarter 2023 Earnings Conference Call
    • Jan 03, 2024: Medytox Announces Executive Appointments in Luvantas, Inc
    • Nov 01, 2023: CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler
    • Oct 31, 2023: SKINVIVE by JUVEDERM Now Available from Dermatologist Dr. Ellen Turner
    • Oct 31, 2023: LG Chem Announces 3Q Management Performance
    • Oct 10, 2023: Anika to Issue Third Quarter 2023 Financial Results on Thursday, November 2, 2023
    • Oct 04, 2023: AbbVie to Host Third-Quarter 2023 Earnings Conference Call
    • Sep 28, 2023: Merz Aesthetics Continues to Fuel Confidence by Expanding Belotero Balance (+) Filler Treatment Areas
    • Sep 19, 2023: Revance Provides Corporate Update at Investor Day
    • Sep 01, 2023: Shanghai Haohai Biological Technology Co. Announces Interim Report 2023
    • Aug 24, 2023: CollPlant Biotechnologies Announces Second Quarter Financial Results For 2023 with Revenues of $10.2 Million
    • Aug 10, 2023: Medytox Appoints Director Kim Jae-wook to Oversee Medical Division
    • Aug 01, 2023: Allergan Aesthetics Announces First Ever JUVEDERM Day
    • Jun 26, 2023: Collplant Achieves Milestone and to Receive $10 Million From Abbvie in Accordance With Its Regenerative Dermal Filler Product Collaboration Agreement
    • Jun 12, 2023: Croma-Pharma announces enrollment of first patient in hyaluronic acid dermal filler clinical trial in China
    • May 30, 2023: Establishment labs announces CE mark approval for minimally invasive surgical tools
    • May 25, 2023: Samyang Holdings to supply 100 billion worth of its filler to China
    • May 15, 2023: SKINVIVE by JUVÉDERM receives U.S. FDA approval
    • Methodology
    • About GlobalData
    • Contact Us
    • Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.